Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Hereditary Sensory and Autonomic Neuropathies × avelumab × 1 year × Clear all

Sponsor

Conditions

Carcinoma, Transitional Cell 13 Urinary Bladder Neoplasms 12 Neoplasms 8 Carcinoma, Renal Cell 8 Carcinoma, Merkel Cell 8 Neoplasm Metastasis 7 Breast Neoplasms 7 Squamous Cell Carcinoma of Head and Neck 6 Triple Negative Breast Neoplasms 4 Stomach Neoplasms 4 Ovarian Neoplasms 4 Melanoma 4 Carcinoma, Non-Small-Cell Lung 4 Uterine Cervical Neoplasms 3 Ureteral Neoplasms 3 Skin Neoplasms 3 Prostatic Neoplasms 3 Colorectal Neoplasms 3 Urethral Neoplasms 2 Small Cell Lung Carcinoma 2 Sarcoma 2 Head and Neck Neoplasms 2 Endometrial Neoplasms 2 Carcinoma, Hepatocellular 2 Urothelial Cancer 1 Turcot syndrome 1 Thymoma 1 Peritoneal Neoplasms 1 Penile Squamous Cell Carcinoma (PSCC) 1 Penile Neoplasms 1

Interventions

Fulvestrant 3 Letrozole 2 Alpelisib 2 venetoclax 1 tivozanib 1 tipifarnib 1 sotorasib 1 serabelisib 1 sapanisertib 1 ribociclib 1 pembrolizumab 1 palbociclib 1 niraparib 1 exemestane 1 ceralasertib 1 cemiplimab 1 capivasertib 1 Trimetazidine 1 Secretin 1 STX-478 1 Radiotherapy 1 Pharmaceutical Preparations 1 Paclitaxel 1 Nivolumab 1 Leuprolide 1 Irinotecan 1 Goserelin 1 Gemcitabine 1 CA-4948 1 CA-19-9 Antigen 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡